About Elypta
Elypta is a company based in Stockholm (Sweden) founded in 2017.. Elypta has raised $27.85 million across 5 funding rounds from investors including European Commission, European Union and Chalmers Ventures. Elypta offers products and services including MIRAM® Kit. Elypta operates in a competitive market with competitors including Guardant Health, GRAIL, Natera, Foundation Medicine and ArcherDX, among others.
- Headquarter Stockholm, Sweden
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Elypta Ab
-
Annual Revenue
$46.88 K (USD)46as on Dec 31, 2018
-
Net Profit
$-648.44 K (USD)-320as on Dec 31, 2018
-
EBITDA
-
Total Equity Funding
$27.85 M (USD)
in 5 rounds
-
Latest Funding Round
$21 M (USD), Series A
Jun 20, 2022
-
Investors
European Commission
& 10 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Elypta
Elypta offers a comprehensive portfolio of products and services, including MIRAM® Kit. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Urine test for detecting cancer through GAGome biomarkers and machine learning analysis
Unlock access to complete
Funding Insights of Elypta
Elypta has successfully raised a total of $27.85M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $21 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $21.0M
-
First Round
First Round
(04 Feb 2019)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2022 | Amount | Series A - Elypta | Valuation | Bonnier Capital | |
| May, 2022 | Amount | Grant - Elypta | Valuation |
investors |
|
| Dec, 2019 | Amount | Seed - Elypta | Valuation | Industrifonden , Sciety |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Elypta
Elypta has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include European Commission, European Union and Chalmers Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Navigare Ventures is focused on early-stage science-driven investments.
|
Founded Year | Domain | Location | |
|
Investments in deep-tech, life sciences, and transformative tech are managed.
|
Founded Year | Domain | Location | |
|
Impact investments are made in startups addressing global challenges.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Elypta
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Elypta
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Elypta Comparisons
Competitors of Elypta
Elypta operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Natera, Foundation Medicine and ArcherDX, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Circulating tumor DNA is screened for early cancer detection.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Elypta
Frequently Asked Questions about Elypta
When was Elypta founded?
Elypta was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Where is Elypta located?
Elypta is headquartered in Stockholm, Sweden.
Is Elypta a funded company?
Elypta is a funded company, having raised a total of $27.85M across 5 funding rounds to date. The company's 1st funding round was a Seed of $6.85M, raised on Feb 04, 2019.
What is the annual revenue of Elypta?
Annual revenue of Elypta is $46.88K as on Dec 31, 2018.
What does Elypta do?
Elypta was founded in 2017 in Stockholm, Sweden, and operates in the biotechnology sector. A liquid biopsy platform is utilized for detecting and monitoring cancer, primarily renal cell carcinoma. Biomarkers are measured, and machine learning algorithms are applied to generate scores against cancer-specific signatures. The platform supports early detection, differential diagnosis, treatment response monitoring, and prediction, often replacing or supplementing medical imaging.
Who are the top competitors of Elypta?
Elypta's top competitors include Guardant Health, GRAIL and Foundation Medicine.
What products or services does Elypta offer?
Elypta offers MIRAM® Kit.
Who are Elypta's investors?
Elypta has 11 investors. Key investors include European Commission, European Union, Chalmers Ventures, Sciety, and Navigare Ventures.